Literature DB >> 2821112

Reconstitution of a functional interleukin 2 receptor in a nonlymphoid cell.

L A Rubin1, G S Hoekzema, D L Nelson, W C Greene, G Jay.   

Abstract

The maintenance of T lymphocytes which are important effectors of immune responses requires the T cell growth factor, interleukin 2 (IL-2). The binding of IL-2 to specific cell-surface receptors (IL-2R) has previously been shown to be essential to the growth and proliferation of activated lymphocytes. A human IL-2R cDNA sequence, placed under the control of the SV40 transcriptional promoter and enhancer, has been transfected into murine L cells. Single cell analysis by autoradiography was used to show that fibroblastic L cells, stably expressing human IL-2R, respond to stimulation with IL-2 by DNA synthesis and proliferation. This response is specifically blocked by the addition of an anti-IL-2R monoclonal antibody, anti-Tac, as previously reported. Neither nonspecific antisera nor 7G7/B6, an anti-IL-2R monoclonal antibody which does not interfere with IL-2 binding to its receptor, had any effect on this response. The induction of DNA synthesis by IL-2 is both rapid and dose-dependent. The ability of IL-2 to stimulate these transfected L cells to proliferate demonstrates that a lymphoid environment is not required for the functional interaction between IL-2 and its receptor, and provides a unique model system for the investigation of the molecular basis for the cellular events mediated by IL-2.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2821112

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  3 in total

1.  Metabolism of Tac (IL2Ralpha): physiology of cell surface shedding and renal catabolism, and suppression of catabolism by antibody binding.

Authors:  R P Junghans; T A Waldmann
Journal:  J Exp Med       Date:  1996-04-01       Impact factor: 14.307

2.  Differential regulation of lymphokine production by distinct subunits of the T cell interleukin 2 receptor.

Authors:  S Burdach; N Zessack; D Dilloo; M Shatsky; D Thompson; L Levitt
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

3.  Monoclonal antibody defining a molecule possibly identical to the p75 subunit of interleukin 2 receptor.

Authors:  T Takeshita; Y Goto; K Tada; K Nagata; H Asao; K Sugamura
Journal:  J Exp Med       Date:  1989-04-01       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.